Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

428.26 0.17 −0.04%
Market cap
$92.9B
P/E
19.0×
Fwd P/E
20.3×
Dividend yield
1.60%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100

Elevance Health, Inc. (ELV) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Elevance Health, Inc. (ELV) trades at a EV/EBITDA of 9.8×. Over the past ten years it has ranged from 3.8× (November 2016) to 11.6× (July 2021); the current reading is higher than 78% of that period. That is below the Healthcare Plans industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 7.7× (1.25%)
FY2024 7.8× (19.47%)
FY2023 9.7× (11.01%)
FY2022 10.9× 7.04%
FY2021 10.2× 19.43%
FY2020 8.5× (5.70%)
FY2019 9.0× (0.49%)
FY2018 9.1× 1.04%
FY2017 9.0× 90.50%
FY2016 4.7× (5.58%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 8.8× 37.85%
Mar 2026 6.4× (17.13%)
Dec 2025 7.7× 13.55%
Sep 2025 6.8× (19.04%)
42 more quarters

Against its own ten years

Low 3.8× High 11.6×
Ten-year median 8.6×
Current reading's percentile 78

EV/EBITDA against peers

Company EV/EBITDA
CNC Centene Corporation compare n/m
CLOV Clover Health Investments, Corp. compare n/m
CI Cigna Group compare 8.3×
CVS CVS Health Corporation compare 8.9×
OSCR Oscar Health, Inc. compare 9.4×
ELV Elevance Health, Inc. 9.8×
HUM Humana Inc. compare 11.5×
MOH Molina Healthcare, Inc compare 15.3×
UNH UnitedHealth Group Incorporated compare 15.5×
Healthcare Plans industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ELV